SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-23-044145
Filing Date
2023-09-15
Accepted
2023-09-15 16:05:57
Documents
4
Period of Report
2023-09-15

Document Format Files

Seq Description Document Type Size
1 PRE 14A ny20010630x1_pre14a.htm PRE 14A 265872
2 logo_ikenax1.jpg GRAPHIC 34202
3 ny20010630x1_pc01.jpg GRAPHIC 524118
4 ny20010630x1_pc02.jpg GRAPHIC 483605
  Complete submission text file 0001140361-23-044145.txt   1701061
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Filer) CIK: 0001835579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40287 | Film No.: 231258730
SIC: 2836 Biological Products, (No Diagnostic Substances)